The conversation emphasizes the global need for ototoxicity monitoring, particularly in areas with limited access to audiology services, where diseases like tuberculosis and cystic fibrosis are prevalent.

Renee shares real-world case studies, such as the use of Shoebox's technology for monitoring patients with multidrug-resistant tuberculosis (MDR-TB) and Meniere’s disease. These examples highlight how accessible tools are making a difference for both patients and clinicians, especially in remote locations. With advancements like noise monitoring during hearing tests, remote audiometry has become more accurate and practical, breaking down barriers for patients unable to attend regular appointments. The conversation concludes by looking toward the future of ototoxicity monitoring, with technology playing a growing role in clinical practice and collaboration across healthcare professionals becoming increasingly essential.

**Learn more about Shoebox here: